RCSI and Bayer Enter Research Collaboration to Improve Haemophilia Treatment
RCSI and Bayer have today announced a research collaboration that aims to improve treatments for people with severe haemophilia. The project will explore new treatments that can be tailored to the severity of each individual’s condition in order to safely and effectively promote blood clotting in people with haemophilia. Haemophilia is an inherited bleeding disorder […]